HealthTree Logo
search more_vert
App Logo
person Sign In / Create Account

Mark Levis, MD

Hematolgoist Oncologist, Program Leader, Hematologic Malignancies and Bone Marrow Transplant Program, Professor of Oncology

21 years treating AML

Clinical Expertise

Dr. Levis’ research focuses on the development of molecularly-targeted therapies for leukemia. He is actively involved in the pre-clinical and clinical development of small molecule inhibitors of protein kinases, including FLT3.


John Hopkins University School Of Medicine: 1550 Orleans St, Baltimore, MD 21287, USA

Get the latest thought leadership on AML delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for AML Newsletter" for AML news, life with AML stories, AML clinical trials, AML 101 articles and events with AML experts.

Thanks to our HealthTree Community for AML Sponsors:

Jazz Pharmaceuticals
Bristol Myers Squibb

Follow Us

facebook instagram twitter youtube